ACCESSION: MSBNK-SMB_Measured-HSA015P0243001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL02_pos_1155': {'bp': 1252805.0, 'sum': 1481836.0}, 'EL08_pos_1155': {'bp': 1244952.0, 'sum': 1439984.0}, 'EL13_pos_1155': {'bp': 1194784.0, 'sum': 1375339.0}, 'EL01_pos_1155': {'bp': 1183102.0, 'sum': 1336475.0}, 'EL21_pos_1155': {'bp': 1021936.0, 'sum': 1161790.0}, 'EL19_pos_1161': {'bp': 1014426.0, 'sum': 1175335.0}, 'EL17_pos_1149': {'bp': 989668.0, 'sum': 1175158.0}, 'EL16_pos_1155': {'bp': 976446.0, 'sum': 1138072.0}, 'EL15_pos_1155': {'bp': 951782.0, 'sum': 1118612.0}, 'EL20_pos_1149': {'bp': 942900.0, 'sum': 1118087.0}, 'EL14_pos_1155': {'bp': 931408.0, 'sum': 1063820.0}, 'EL18_pos_1149': {'bp': 775755.0, 'sum': 949385.0}, 'EL09_pos_1155': {'bp': 741664.0, 'sum': 879540.0}, 'EL06_pos_1155': {'bp': 731894.0, 'sum': 957000.0}, 'EL03_pos_1197': {'bp': 718473.0, 'sum': 1015593.0}, 'EL07_pos_1155': {'bp': 696054.0, 'sum': 827893.0}, 'EL10_pos_1155': {'bp': 679632.0, 'sum': 816379.0}, 'EL05_pos_1155': {'bp': 619493.0, 'sum': 804100.0}, 'EL22_pos_1161': {'bp': 576268.0, 'sum': 756464.0}, 'EL04_pos_1161': {'bp': 537758.0, 'sum': 688801.0}, 'EL12_pos_1155': {'bp': 433924.0, 'sum': 576717.0}, 'EL23_pos_1155': {'bp': 404728.0, 'sum': 525849.0}, 'EL11_pos_1155': {'bp': 366427.0, 'sum': 487637.0}, 'EL24_pos_1161': {'bp': 338975.0, 'sum': 448641.0}}
COMMENT: RETENTION_TIME_STDEV 0.004
COMMENT: PRECURSOR_M/Z_RAW 243.183529
COMMENT: PRECURSOR_M/Z_STDEV 0.000084
COMMENT: PRECURSOR_IN_MS1 mz 243.183429; int 25.333; delta(ppm) 1.076233
COMMENT: PROPOSED_CHARGE_STATE +1; mz 244.187301; int 2.947; cor 0.920
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 8
COMMENT: PROPOSED_MF SevenGoldenRules 0.929; C9H27N2O3P; [M+H]+; delta(ppm) 0.929076
COMMENT: PROPOSED_MF SIRIUS5_Sirius 11.554; C11H22N4O2; [M+H]+; delta(ppm) 7.716838
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1.000; C16H22N2; [M+H]+; delta(ppm) -8.825147
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C11H22N4O2; [M+H]+; delta(ppm) 7.716838
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.138; C11H22N4O2; [M+H]+; delta(ppm) 7.716838
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.610; C13H24NO3; [M+H]+; delta(ppm) 2.195587
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.396; C16H22N2; [M+H]+; delta(ppm) -8.825147
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H22N4O2; [M+H]+; delta(ppm) 7.716838
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.254; JRVLXLACCVMFNC-UHFFFAOYSA-N; [M+H]+; CC(C)(C=C)N1C=C(C2=CC=CC=C21)CN(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.087; BACHGBRTDFKCGH-UHFFFAOYSA-N; [M+H]+; C=1C=CC2=C(C1)C3=C(N2CCCNC)CCCC3
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; JJPMUZRSJKMFRK-RRFHKOGJNA-N; [M+H]+; C[C@@H]1C[C@H]2CC3=C(C=CC=N3)[C@]3(C1)NCCC[C@H]23
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; YVFVTDLZSKSFCQ-UHFFFAOYNA-N; [M+H]+; CC1C(C)(C)C2=C(C3=NC=NC=C3CC2)C1(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; SUIUNSOOOSXFKY-UHFFFAOYSA-N; [M+H]+; CC1=CC(=CC(=C1N)C)C2=CC(C(C=C2)N)(C)C
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -390.619; NTKWXRSEJQGLRX; [M+H]+; 2-hydrazinyl-2-oxo-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -417.170; SXRZZKRPPUYMMG; [M+H]+; 1,3-Bis(3-aminopropyl)-5,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -446.645; KBBOBJTXLGJSQT; [M+H]+; 2-Hydrazino-5-ethyl-5-sec-pentylbarbituric acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.036; NTKWXRSEJQGLRX; [M+H]+; 2-hydrazinyl-2-oxo-N-(2,2,6,6-tetramethylpiperidin-4-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.814; BPFZDJZWMMPWGW; [M+H]+; N-methyl-2-[4-[2-(methylamino)-2-oxoethyl]-1,4-diazepan-1-yl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -103.490; XDULRDRVBDTZIA; [M+H]+; N-[2-(dimethylamino)ethyl]-2-(4-formylpiperazin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.910; IZYJHEWOTZGTBV; [M+H]+; 2-[(2-piperazin-1-ylacetyl)amino]-N-propylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.332; ZXGWVKSJHRIKKX; [M+H]+; N-[2-(dimethylamino)ethyl]-2-(4-methylpiperazin-1-yl)-2-oxoacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -111.213; TYEQMBMGBVYFFS; [M+H]+; N-[3-(dimethylamino)propyl]-4-formylpiperazine-1-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.272; HVRGOKDYSGCXTO; [M+H]+; N-[1-[4-(2-hydroxyiminopropyl)-1,4-diazepan-1-yl]propan-2-ylidene]hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -116.457; OHGASDGZCICZJY; [M+H]+; 2-[4-(2-aminoacetyl)piperazin-1-yl]-N-propylacetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.100; IFIKBQIESGNUCV; [M+H]+; N-(2-acetamidoethyl)-2-(1,4-diazepan-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.292; NCFVXMXBGYMNTO; [M+H]+; N-(2-aminoethyl)-2-oxo-2-(4-propylpiperazin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.395; XNRDOXFGJLQCAG; [M+H]+; N-(2-aminoethyl)-2-oxo-2-(4-propan-2-ylpiperazin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.085; BPFZDJZWMMPWGW; [M+H]+; N-methyl-2-[4-[2-(methylamino)-2-oxoethyl]-1,4-diazepan-1-yl]acetamide
COMMENT: CONFIDENCE Level 5: Exact mass of interest 243.183429; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 1.861
MS$FOCUSED_ION: PRECURSOR_M/Z 243.183429
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-0900000000-ddf2cd127f119ee4c01a
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  57.0701077 7.0591 ? 57.070824 1.0864 2.67 0.4965 19
  58.0652806 7.4479 ? 58.066001 1.1711 1.91 0.8792 22
  60.0810153 43.3197 ? 60.081742 0.5160 4.56 0.9774 24
  104.1070405 999.0000 ? 104.107614 0.3074 0.00 1.0000 24
  105.1102591 32.3102 ? 105.110822 0.6565 3.22 0.9487 24
PK$NUM_PEAK: 5
PK$PEAK: m/z int. rel.int.
  57.070108 7.06 7
  58.065281 7.45 7
  60.081015 43.32 43
  104.107041 999.00 999
  105.110259 32.31 32
//
